US judge strikes down FDA limits on abortion pill mifepristone
A federal judge ruled that the FDA's restrictions on mifepristone, a key abortion drug, were arbitrary and capricious. The decision lifts requirements such as in-person dispensing and signature mandates, potentially expanding access to medication abortion nationwide. This ruling is significant as it could reshape how the drug is distributed and may trigger further legal challenges.